 |
| BY READING THIS EMAIL YOU CERTIFY YOU HAVE READ THE DISCLAIMER BELOW AND THE FULL DISCLAIMER PROVIDED THROUGH A LINK AT THE END OF THIS EMAIL. This is a paid advertisement. SmallCapVoice.com, Inc. is not responsible or held liable for the information in the press releases issued by the companies in these emails. Please always do your own due diligence. |
|
   |
| RXMD Featured Once Again in International Trade Publications for its Adherence Efforts |
|
 Hot Stock to Watch |
Company: Progressive Care Inc. (OTCQB: RXMD)
|
Last:
Price: 0.0583
Change (%): + 0.0083 (16.6)
Volume: 53,113 |
 |
Progressive Care Inc. Garners International News Coverage in Leading Trade Publications for Its Efforts to Improve Adherence
MIAMI, Dec. 04, 2018 (GLOBE NEWSWIRE) - Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered notable international media coverage in top pharmacy industry publication World Pharma Today stressing the importance of adherence and compliance in the space of medicine.
“We are honored to have Progressive Care’s efforts toward improving patient outcomes highlighted for the second time in such a noteworthy publication,” said S. Parikh Mars, CEO of Progressive Care Inc. “We are passionate about educating the public to be aware that pharmacists play a fundamental role in ensuring patient adherence and wellbeing.”
In a contributed article titled “The Pharmacist Perspective: Medication Adherence & Compliance”, published November 26, 2018, in World Pharma Today, Mars focuses on adherence and its significance for patients who are prescribed medications. Mars also dives deep into non-adherence and how it has caused a tremendous danger to our overall healthcare system.
In the piece, Mars writes: “Pharmacies influence patient behavior, improve adherence, and reduce costs across the spectrum. In order to do this, pharmacists must know their patients and use best practices to achieve results.”
Continue Reading
|
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, publicly available material information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that this information, which originates from third parties, is accurate. We do not have the resources to confirm the accuracy of all information obtained from third parties. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
